Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Product

Td-Impfstoff

1 clinical trial

2 indications

Indication
Diphtheria
Indication
Tetanus
Clinical trial
Single Blind, Randomized, Comparative, Multicentre Clinical Trial of the Immunogenicity and Safety of Booster Immunization With Bivalent Vaccine Against Tetanus and Diphtheria CLODIVAC (IBSS Biomed S.A.) and Td-Impfstoff Mérieux (Sanofi Pasteur) in Healthy Adults.
Status: Active (not recruiting), Estimated PCD: 2024-03-04